ESCRS - PO367 - To Evaluate The Postoperative Functional And And Morphological Findings Including Endothelial Cell Count In Patients With Fuchs Dystrophy After Implantation Of A Modern Hydrophobic Edof Iol Using Flacs.

To Evaluate The Postoperative Functional And And Morphological Findings Including Endothelial Cell Count In Patients With Fuchs Dystrophy After Implantation Of A Modern Hydrophobic Edof Iol Using Flacs.

Published 2025 - 43rd Congress of the ESCRS

Reference: PO367 | Type: Free paper | DOI: 10.82333/9p9d-ze65

Authors: Md Oliullah Abdal 1 , Adnan Shallal Al Hassani* 2 , Omar Dawood Salman 1

1Optometry,Vision Eye Care Centre,Kalar city,Iraq, 2Ophthalmology,Vision Eye Care Centre,Kalar city,Iraq

Purpose

To evaluate the postoperative functional and  and morphological findings  in patients with Fuchs dystrophy after implantation of a modern hydrophobic EDOF IOL using FLACS.

 

Setting

Augenzentrum ONE, Alter Markt 1-2, 24105 Kiel

 

Methods

We retrospectively analyzed the pre- and postoperative findings of 30 patients with Fuchs dystrophy with a follow up of up to X months after FLACS and implantation of a hydrophobic EDOF IOL (Acunex vario, Telenon surgical). The surgery was performed with the Lensar Femto Laser platform by a single surgeon. Postoperatively among other results endothelial cell count, UCDVA and UCIVA and CDVA was examined. Target refraction in the non dominant eye was -0.5 dpt.

Results

Mean age of the patients was 74 years. Average endothelial cell count was 2500mm2. Average central corneal thickness was 570mm. Corrected distance visual acuity improved from 02 logMar to 0.0 LogMar. Binocular UCDVA postoperatively was 0.1 LogMar and binocular UCIVA 0.20LogMar. No patient showed a prolonged corneal edema postoperatively. All patients had a clear cornea without signs of endothelial decompensation in the follow up period. Endothelial cell loss in the follow up period was up to in average 10% in the follow up period.

 

Conclusions

The combination of FLACS and an hydrophobic EDOF IOL showed good functional results in cataract patients with early stage Fuchs dystrophy. It is a safe procedure with good and predictable postoperative results. Spectacle independence in daily life significantly increased. We conclude that early stage Fuchs dystrophy is no contraindication for the use of a EDOF IOL. The use of FLACS with low EPT minimizes endothelial cell loss. The use of a hydrophobic IOL is recommended in Fuchs dystrophy regarding the possible risk of a further endothelial transplant with intracameral gas injection to reduce the risk of lens clouding postoperatively.